StockData
MindWalk Holdings Corp. logo

MindWalk Holdings Corp. (HYFT) company profile

HYFTNasdaqPharmaceutical PreparationsFiscal year ends April 30
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 20-F on Jul 23, 2026Score 7/30
$0.91−0.03 (-3.32%)

Close on Nov 17, 2026Market cap $42.35MP/E –Yield –

About MindWalk

Pharmaceutical Preparations, SIC 2834

MindWalk Holdings Corp. is a biotechnology company focused on therapeutic antibody discovery and development, biocomputing, and artificial intelligence-driven biological research. The company operates through its subsidiaries, including BioStrand and ImmunoPrecise Antibodies, providing contract research services, custom antibody generation, protein production, and cryostorage solutions. Its offerings also incorporate proprietary platforms and computational tools designed to support biomedical workflows. MindWalk serves clients across the pharmaceutical, biotechnology, and academic research sectors.

The enterprise maintains operations and facilities across North America and Europe, with business and laboratory presences in Canada, the United States, the Netherlands, and Belgium, including sites in Victoria, Utrecht, and Oss. MindWalk Holdings Corp. is headquartered in Austin, Texas, United States.

Summary of the business section of MindWalk's latest annual report, written by StockData.

Company profile

Company

Legal name
MindWalk Holdings Corp.
Founded
1983
Headquarters
Victoria, British Columbia, Canada
Address
3204-4464 Markham Street
Phone
(604) 806-0626
Industry
Pharmaceutical Preparations
Incorporated in
A1
Fiscal year ends
April 30
Auditor
Grant Thornton, Houston, Texas

Stock & identifiers

Ticker
HYFT
Former tickers
IPA until Jul 23, 2026
Exchange
Nasdaq
IPO date
Jan 7, 2002
Shares outstanding
47M, Apr 30, 2026
Filer category
Non-accelerated filer
Stock splits
1-for-5 reverse, Nov 23, 2020; 1-for-3 reverse, Sep 2, 2016; 1-for-10 reverse, Sep 13, 2011
SEC CIK
1715925
CUSIP
602687105
ISIN
CA6026871054
FIGI
BBG000CR68W7
Share class FIGI
BBG001S60P25
LEI
549300VULMFHRONS7K42
EIN
00-0000000

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

No recent ownership filings by officers or directors

MindWalk's leadership is listed in its proxy statement (Form DEF 14A).

Corporate history

Events identified from SEC filings

DateEventDetails
Sep 3, 2025Name changeName changed from ImmunoPrecise Antibodies Ltd. to MindWalk Holdings Corp.

See a number that looks wrong?